The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab in patients with locally recurrent or metastatic triple-negative breast cancer.
 
Lei Fan
No Relationships to Disclose
 
Xiyu Liu
No Relationships to Disclose
 
Xi Jin
No Relationships to Disclose
 
Yunsong Yang
No Relationships to Disclose
 
Li Chen
No Relationships to Disclose
 
Xin Hu
No Relationships to Disclose
 
Zhonghua Wang
No Relationships to Disclose
 
Yizhou Jiang
No Relationships to Disclose
 
Zhimin Shao
No Relationships to Disclose